Medium

Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

·

Sep 2, 2020

The Emerging Field of Deep Biomarkers of Aging — Why did we sell Deep Longevity to Regent Pacific?

As a CEO of Deep Longevity, which has just been acquired by Regent Pacific (HKEX: 0575) I now have to bee very careful about what I say…

The Emerging Field of Deep Biomarkers of Aging — Why did we sell Deep Longevity to Regent Pacific?

Alex Zhavoronkov, PhD

·

Jul 13, 2020

Psychological aging and how to slow it

Did you know that we are aging at the psychological level and there is a way to think, feel, and behave as a younger individual?

https://www.forbes.com/sites/alexzhavoronkov/2020/07/13/this-stanford-scientist-can-make-you-feel-and-think-younger-interview

Alex Zhavoronkov, PhD

·

Sep 20, 2019

Insilico Medicine is Hiring Key Business Development Executives

During our 5-year journey, we tried many things, made many mistakes, and got famous in several industries primarily due to our commitment…

Insilico Medicine is Hiring Key Business Development Executives

Alex Zhavoronkov, PhD

·

Sep 10, 2019

Insilico secures $37 million from top-tier experts— now what?

For the many experts in AI, pharma, and longevity industries who know our team well the recent announcement of our $37 million round may…

Insilico secures $37 million from top-tier experts— now what?

Alex Zhavoronkov, PhD

·

Sep 10, 2019

Insilico Medicine 完成3700万美元B轮融资，启明创投领投

9月10日，香港 — — AI药物研发公司Insilico Medicine日前完成了3700万美元的B轮融资，启明创投领投，斯道资本、F-Prime Capital、礼来亚洲基金、创新工场、百度风投、兰亭投资、BOLD Capital…

In

InsilicoMedicine

by

Alex Zhavoronkov, PhD

·

Sep 10, 2019

Insilico Medicine Secures $37M in Series B Funding Led by Qiming Venture Partners

Original press release by Qiming Venture Partners

Alex Zhavoronkov, PhD

·

Jun 27, 2019

We Know How to Price Options, What About Pricing Data?

Paper reference: The Advent of Human Life Data Economics

We Know How to Price Options, What About Pricing Data?

Alex Zhavoronkov, PhD

·

Feb 20, 2019

How To Live This Life Better: Effective Altruism In The Context Of Longevity

There is no better feeling than being firmly convinced that you are doing the right thing in life. This is the comfort provided by most…

How To Live This Life Better: Effective Altruism In The Context Of Longevity

In

InsilicoMedicine

by

Alex Zhavoronkov, PhD

·

Feb 8, 2019

Insilico to contribute to Oxford CDT research and educational program in AI

On Monday, February 4th, 2019 the Big Data Institute announced a new doctoral training program:

Insilico to contribute to Oxford CDT research and educational program in AI

In

InsilicoMedicine

by

Alex Zhavoronkov, PhD

·

Jan 16, 2019

I would like to congratulate our investors, friends, business partners, and fellow longevity…

Here are the details from the press release on the Business Wire today:

I would like to congratulate our investors, friends, business partners, and fellow longevity…

Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

Founder of Insilico Medicine, adj. prof at the Buck. I speak at 40+ events per year on AI for drug discovery and longevity research. PubMed: Zhavoronkov+A

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech